WallStreetZenWallStreetZen

NASDAQ: SRTS
Sensus Healthcare Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SRTS past earnings growth

How has SRTS's earnings growth performed historically?
Company
-97.96%
Industry
88.04%
Market
61.16%
SRTS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SRTS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

SRTS past revenue growth

How has SRTS's revenue growth performed historically?
Company
-45.2%
Industry
9.4%
Market
16.96%
SRTS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SRTS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SRTS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SRTS earnings and revenue history

Current Revenue
$24.4M
Current Earnings
$485.0k
Current Profit Margin
2%

SRTS Return on Equity

Current Company
1%
Current Industry
10.5%
Current Market
188%
SRTS's Return on Equity (1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SRTS announces earnings.

SRTS Return on Assets

Current Company
0.9%
Current Industry
5.3%
SRTS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SRTS Return on Capital Employed

Current Company
1.32%
Current Industry
8.3%
SRTS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SRTS vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SRTS$24.41M$1.11M$485.00k-1.58%-65.36%
APYX$52.35M-$17.89M-$18.71M+25.82%N/A
ICCM$3.23M-$15.25M-$14.65M+18.69%N/A
HYPR$11.03M-$43.18M-$44.24M+331.79%N/A
MOVE$0.00-$28.90M-$29.28MN/AN/A
View Top Medical Device Stocks

SRTS earnings dates

Next earnings date
May 9, 2024

Sensus Healthcare Earnings & Revenue FAQ

What were SRTS's earnings last quarter?

On Invalid Date, Sensus Healthcare (NASDAQ: SRTS) reported Q4 2023 earnings per share (EPS) of $0.26, up 52.94% year over year. Total Sensus Healthcare earnings for the quarter were $4.21 million. In the same quarter last year, Sensus Healthcare's earnings per share (EPS) was $0.17.

If you're new to stock investing, here's how to buy Sensus Healthcare stock.

What was SRTS's earnings growth in the past year?

As of Q2 2024, Sensus Healthcare's earnings has grown -97.96% year over year. This is 186 percentage points lower than the US Medical Devices industry earnings growth rate of 88.04%. Sensus Healthcare's earnings in the past year totalled $485.00 thousand.

What is SRTS's earnings date?

Sensus Healthcare's earnings date is Invalid Date. Add SRTS to your watchlist to be reminded of SRTS's next earnings announcement.

What was SRTS's revenue last quarter?

On Invalid Date, Sensus Healthcare (NASDAQ: SRTS) reported Q4 2023 revenue of $12.57 million up 4.1% year over year. In the same quarter last year, Sensus Healthcare's revenue was $13.10 million.

What was SRTS's revenue growth in the past year?

As of Q2 2024, Sensus Healthcare's revenue has grown -45.2% year over year. This is 54.59 percentage points lower than the US Medical Devices industry revenue growth rate of 9.4%. Sensus Healthcare's revenue in the past year totalled $24.41 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.